3 ASX All Ordinaries shares being sold off following FY22 results

These shares are suffering on the release of full-year earnings.

| More on:
An older man wearing glasses and a pink shirt sits back on his lounge with his hands behind his head and blowing air out of his cheeks.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries Index (ASX: XAO) is in the green today, lifting 0.72%, but these shares are defying its gains. They're each trading lower on the back of their companies' latest earnings being released.

Let's take a look at how these three ASX All Ordinaries companies performed in financial year 2022 (FY22).

Atomos Ltd (ASX: AMS)

The Atomos share price is plummeting 16% to trade at 24 cents after the company dropped its earnings for FY22. That's despite the manufacturer and distributor of video equipment posting record revenue for the period.

That's right, Atomos brought in $82 million of revenue in FY22, a 4.3% improvement on that of the prior corresponding period (pcp).

However, its net profit after tax (NPAT) tumbled 243% to a $6 million loss and its earnings before interest, tax, depreciation, and amortisation (EBITDA) fell 115% to a $1.2 million loss.

The company's results were weighed down by several one-off expenses. But it expects the momentum experienced in the final quarter will continue into FY23.

PPK Group Limited (ASX: PPK)

The PPK share price is also suffering on the back of the company's full-year earnings. It's falling 0.9% right now to trade at $1.62.

That's despite the company's revenue doubling in FY22, lifting to $1.6 million. Its loss also came in at half that of FY21, improving to reach ($2.5 million).

However, the company declined to pay a final dividend for the second year in a row, bringing its full-year payout to 2.81 cents per share. That's down from FY21's total dividends of 3.5 cents.

Commentary on some of the company's segments might also be weighing the stock down today.

CogState Limited (ASX: CGS)

Finally, ASX All Ordinaries share CogState is plunging 5.6% to trade at $1.60. Its fall has come on the back of full-year results released by the cognition-focused technology company.

The share price dip is despite the company posting around US$45 million of revenue for the period, a 37.6% increase on that of the pcp.

It also brought in US$13 million of EBITDA – a 127.8% lift, and $7.5 million of NPAT – a 43.7% improvement.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Atomos Ltd and CogState Limited. The Motley Fool Australia has positions in and has recommended CogState Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

a man in a shirt and tie holds his chin in thoughtful contemplation and looks skywards as if thinking about something while a graphic of a road with many ups and downs unfurls behind him.
Earnings Results

What's with the Neuren Pharmaceuticals share price today?

The full market reaction to the Daybue developer's FY23 earnings report won't be seen until tomorrow.

Read more »

Two workers at an oil rig discuss operations.
Earnings Results

2 ASX energy shares going gangbusters on today's earnings results

The ASX energy shares are drawing investor interest today after releasing their half-year earnings results.

Read more »

Man pointing at a blue rising share price graph.
Earnings Results

This ASX 300 stock just jumped 12%! Here's why

The ASX 300 stock is impressing investors with its half-year earnings results.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Earnings Results

Mesoblast share price tumbles on US$32.5m half-year loss

This biotech continues to burn cash.

Read more »

Man and woman sitting at casino table playing poker
Earnings Results

Star Entertainment share price jumps 5% on strengthening outlook

ASX 200 investors are bidding up the Star Entertainment share price on Thursday.

Read more »

Happy couple doing online shopping.
Earnings Results

Harvey Norman share price jumps to 52-week high on half-year results

A sharp profit decline isn't putting off investors today.

Read more »

Health professional working on his laptop.
Healthcare Shares

Ramsay Health Care share price falls on profit crunch and dividend cut

This private hospital operator continues to battle with higher costs.

Read more »

defence personnel operating and discussing defence technology
Earnings Results

Why this ASX defence stock soared 16% on Wednesday

Growing defence spending is helping this little ASX company find its feet again.

Read more »